Found 770 matching trials
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Kaiser Franz Josef Hospital
Learn More & Join Trial
Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 PHASE2 This is a single-center, prospective, single-arm, open-label phase II study...
Location
Asan Medical Center
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy PHASE1 Quisinostat besides its own efficacy, which can potentially lead to better ...
Show More Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Learn More & Join Trial
Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer PHASE2 Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts fo...
Show More Location
Sixth People's Hospital of Luoyang
Learn More & Join Trial
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma PHASE2 The aim of the study is to determine if intervening with combined local the...
Show More Location
Fudan Universtiy Shanghai Cancer Center
Learn More & Join Trial
Study of Pemetrexed for Second-Line Pancreas Cancer PHASE2 This study is for patients with pancreatic cancer that has grown and/or spr...
Show More Location
Georgetown University Hospital/Lombardi Cancer Center
Learn More & Join Trial
Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study PHASE2 This is an investigator-initiated, prospective, multicenter, single-arm pha...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy N/A Post-authorization, prospective follow-up, multi-centre, national study to ...
Show More Location
Hospital Juan Ramón Jiménez
Learn More & Join Trial
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations PHASE1 BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Show More Status
Active Not Recruiting
Location
University of Alabama
Learn More & Join Trial
Talazoparib Maintenance Therapy in Triple-negative Breast Cancer PHASE2 The investigators propose a randomized phase II clinical trial of talazopar...
Show More Location
Yonsei University College of Medicine
Learn More & Join Trial